, Volume 19, Issue 1–2, pp 44–48 | Cite as

Revue de presse de l’AERIO

  • L. Hirsch
  • C. Le Tourneau
  • B. Verret
  • S. Dumont

AERIO press review


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, et al (2015) Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E86CrossRefPubMedGoogle Scholar
  2. 2.
    Tang LQ, Chen QY, Fan W, et al (2013) Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol 31: 2861–69CrossRefPubMedGoogle Scholar
  3. 3.
    Wei WI, Sham JS (2005) Nasopharungeal carcinoma. Lancet 365:2041–54CrossRefPubMedGoogle Scholar
  4. 4.
    Wang J, Li J, Hong X, et al (2008) Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma. Oral Oncol 44:464–70CrossRefPubMedGoogle Scholar
  5. 5.
    Ngan RK, Yiu HH, Lau WH, et al (2002) Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol 13:1252–58CrossRefPubMedGoogle Scholar
  6. 6.
    Tan T, Lim WT, Fong KW, et al (2015) Concurrent chemoradiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 91:952–60CrossRefPubMedGoogle Scholar


  1. 1.
    Buckner JC, Shaw EG, Pugh SL, et al (2016) Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med 374:1344–55CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Shaw EG, Wang M, Coons SW, et al (2012) Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol 30:3065–70CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Cairncross JG, Wang M, Jenkins RB, et al (2014) Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 32:783–90CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    van den Bent MJ, Brandes AA, Taphoorn MJ, et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344–50CrossRefPubMedGoogle Scholar

Copyright information

© Lavoisier 2017

Authors and Affiliations

  1. 1.AERIOParisFrance
  2. 2.Institut CurieParisFrance
  3. 3.Comité neuro-oncologieGustave-RoussyFrance

Personalised recommendations